公司簡(jiǎn)介
上海中信國(guó)健藥業(yè)股份有限公司上海中信國(guó)健藥業(yè)股份有限公司(以下簡(jiǎn)稱“中信國(guó)健”)是由中國(guó)中信集團(tuán)有限公司旗下中信泰富有限公司投資控股的生物醫(yī)藥高新技術(shù)企業(yè)。公司自2002年創(chuàng)建以來(lái),專注于抗體藥物的研發(fā)、中試和產(chǎn)業(yè)化,現(xiàn)已發(fā)展成為國(guó)內(nèi)抗體制藥領(lǐng)域的領(lǐng)軍企業(yè),提供覆蓋治療腫瘤、自身免疫性疾病、抗器官移植排斥反應(yīng)等重大疾病領(lǐng)域的靶向藥物。作為一家以研發(fā)為基礎(chǔ)的生物制藥公司,中信國(guó)健已成功構(gòu)建了抗體藥物開(kāi)發(fā)和產(chǎn)業(yè)化平臺(tái)并掌握核心技術(shù),具備持續(xù)開(kāi)發(fā)新藥的創(chuàng)新能力。公司生產(chǎn)規(guī)模位居行業(yè)前列。shanghai cp guojian pharmaceutical co., ltd. (cpgj) is a high-tech bio -pharmaceutical company which is co-invested and led by china international trust and investment corporation (citic) group. cpgj focuses on r&d, pilot development, industrialization and commercialization of monoclonal antibody drugs. established in 2002 and going through more than ten years of growth, cpgj has become a leading player in china’s domestic therapeutic mab area. it has built up the largest production capacity for monoclonal antibody drugs in china and further expansion is undergoing within cpgj’s strategic planning. the company’s product pipeline has covered the therapeutic solutions for critical diseases in oncology, transplantation and autoimmune disorders. its drug for rheumatic disease has maintained a leading domestic market share in the biological anti-rheumatic drugs field in china.dedicated to sharpening its research & development capability, cpgj has successfully produced key technological know-hows for the development and industrialization of monoclonal antibody drugs. as cpgj’s wholly owned r&d organization, biotechnology institute of shanghai cp guojian focuses on discovery and early development of therapeutic antibodies and proteins, as well as innovation of technologies and processes to support drug development. the institute has established a comprehensive technological platform with a strong capability to take a drug development program from early discovery through cmc stage.現(xiàn)由于公司發(fā)展需要,誠(chéng)聘具有創(chuàng)新精神和成就事業(yè)理想的優(yōu)秀人才加盟。請(qǐng)符合條件的應(yīng)聘者將中英文簡(jiǎn)歷等信息發(fā)送e-mail至:hr@cpgj-pharm.com (請(qǐng)?jiān)卩]件題目上注明應(yīng)聘職位等信息)查看更多
聯(lián)系信息



登錄查看聯(lián)系信息
登錄/注冊(cè)
工商信息
- 公司名稱: 三生國(guó)健藥業(yè)(上海)股份有限公司
- 公司狀態(tài): 存續(xù)
- 行業(yè): 醫(yī)藥生物 — 生物制品Ⅱ
- 公司類型: 股份有限公司(港澳臺(tái)投資、上市)
- 地址: 中國(guó)(上海)自由貿(mào)易試驗(yàn)區(qū)李冰路399號(hào)
- 企業(yè)規(guī)模: 1360
- 法人代表: LOU JING
- 注冊(cè)資本: 61621.1413萬(wàn)人民幣
- 注冊(cè)時(shí)間: 2002年01月25日
- 注冊(cè)號(hào): 310115400089528
- 統(tǒng)一社會(huì)信用代碼: 91310000735408592G
- 組織機(jī)構(gòu)代碼: 735408592
- 登記機(jī)關(guān): 上海市市場(chǎng)監(jiān)督管理局
- 注冊(cè)地址: 中國(guó)(上海)自由貿(mào)易試驗(yàn)區(qū)李冰路399號(hào)
- 營(yíng)業(yè)期限: 2002-01-25至無(wú)固定期限
- 核準(zhǔn)日期: 2020年09月15日
-
經(jīng)營(yíng)范圍:
生物制品、基因工程產(chǎn)品、中西藥業(yè)、生物試劑的研究、開(kāi)發(fā)(除人體干細(xì)胞、基因診斷與治療技術(shù)開(kāi)發(fā)和應(yīng)用);生物工程產(chǎn)品的生產(chǎn)、銷售自產(chǎn)產(chǎn)品;相關(guān)項(xiàng)目研發(fā)成果的技術(shù)轉(zhuǎn)讓、技術(shù)服務(wù)和技術(shù)咨詢。【依法須經(jīng)批準(zhǔn)的項(xiàng)目,經(jīng)相關(guān)部門批準(zhǔn)后方可開(kāi)展經(jīng)營(yíng)活動(dòng)】
登錄查看工商信息
登錄/注冊(cè)
- 相關(guān)企業(yè)
- 城市招聘
- 熱門職位
- 公司招聘
- 人才網(wǎng)
- 企業(yè)名錄
- 職場(chǎng)資訊
當(dāng)前位置: 人才網(wǎng) > 佛山人才網(wǎng) > 上海中信國(guó)健藥業(yè)股份有限公司招聘
手機(jī)版: 上海中信國(guó)健藥業(yè)股份有限公司招聘
智通直聘為您提供2025最新中信國(guó)健藥業(yè)招聘,更有中信國(guó)健藥業(yè)招聘簡(jiǎn)介、工商信息、基本信息、公司地址和公司環(huán)境等詳細(xì)信息,登陸智通直聘網(wǎng)站或APP,助你快速通過(guò)中信國(guó)健藥業(yè)招聘,開(kāi)啟嶄新的職業(yè)生涯。